Valiant Barrier
- RxCUI
- 1094065
- RxNorm name
- Valiant Barrier
- Term type
- BN
- Status
- Active
- Updated
- 2026-07-17 21:39:25
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 042011
- Active start
- 042011
- Multiple ingredient
- YES
- Branded
- YES
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| dodecylbenzenesulfonic acid | 1094060 |
| lactate | 114202 |
Source Vocabulary Codes#
| Code type | Value | Category |
|---|---|---|
| RXNAV_STR | Valiant Barrier | NAMES |
| RxNorm Name | Valiant Barrier | NAMES |
| TTY | BN | ATTRIBUTES |
| RxCUI | 1094065 | CODES |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | G01AD | Organic acids | ATC1-4 | lactic acid | |
| FDASPL | N0000175833 | Acidifying Activity | MOA | has_moa | lactic acid |
| MEDRT | D001557 | Benzenesulfonates | CHEM | has_ingredient | dodecylbenzenesulfonic acid |
| MEDRT | D019344 | Lactic Acid | CHEM | has_ingredient | lactate |
| MEDRT | D019344 | Lactic Acid | CHEM | has_ingredient | lactic acid |
| MEDRT | D003872 | Dermatitis | DISEASE | may_prevent | lactic acid |
| MEDRT | D003872 | Dermatitis | DISEASE | may_treat | lactic acid |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | lactic acid |
| MEDRT | D005148 | Facial Dermatoses | DISEASE | may_treat | lactic acid |
| MEDRT | N0000009915 | Unknown Cellular or Molecular Interaction | MOA | has_moa | lactic acid |
| MEDRT | N0000009735 | Decreased Skin Keratinization | PE | has_pe | lactic acid |
| MEDRT | N0000009035 | Emollient Activity | PE | has_pe | lactic acid |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | BN_CARDINALITY | multi |
| ATTRIBUTES | GENERAL_CARDINALITY | MULTI |
| ATTRIBUTES | RXNAV_VET_DRUG | US |
| ATTRIBUTES | TTY | BN |
| CODES | RxCUI | 1094065 |
| NAMES | RXNAV_STR | Valiant Barrier |
| NAMES | RxNorm Name | Valiant Barrier |